ERACHEM COMILOG, INC. – Trademark Portfolio
Entity Type: 03
ERACHEM COMILOG, INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 6 filings in this category. The portfolio also extends into Class 6 (Metal Goods) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ERACHEM and TECMANGAM. The owner is based in BALTIMORE, MD.
610 PITTMAN ROAD
BALTIMORE, MD 21226
Showing of trademarks Trademarks
Trademark Classifications
ERACHEM COMILOG, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Common metals and their alloys; metal building materials; transportable buildings of metal
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ERACHEM COMILOG, INC. have?
ERACHEM COMILOG, INC. has 7 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 cancelled.
What trademark classes does ERACHEM COMILOG, INC. file in?
ERACHEM COMILOG, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 6 (Metal Goods), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are ERACHEM COMILOG, INC.'s most well-known trademarks?
ERACHEM COMILOG, INC.'s registered trademark portfolio includes well-known marks such as ERACHEM and TECMANGAM. These are among 2 currently registered trademarks in the portfolio.
What is ERACHEM COMILOG, INC.'s trademark registration success rate?
ERACHEM COMILOG, INC. has a 29% trademark registration rate, with 2 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.